Takemi Yoshida

4.1k citations
156 papers · 3.5k indexed · h-index 30
Topics
Pharmacogenetics and Drug Metabolism (41 papers)Heme Oxygenase-1 and Carbon Monoxide (28 papers)Drug Transport and Resistance Mechanisms (20 papers)

In The Last Decade

Takemi Yoshida

154 papers receiving 3.4k citations

Peers

Takemi Yoshida
Comparison fields: 5 of 133
  • Molecular Biology 1.8k
  • Pharmacology 627
  • Oncology 434
  • Pharmacology 321
  • Cancer Research 270
Replace Gi‐Su Oh with:
Gi‐Su Oh South Korea
Xiu Jun Wang China
Bao Ting Zhu United States
Ichiro Hatayama Japan
Othman A. Al‐Shabanah Saudi Arabia
Siyaram Pandey Canada
Cecil B. Pickett United States
Truyen Nguyen United States
Qiusheng Zheng China
Zahurin Mohamed Malaysia
Takemi Yoshida relative to Gi‐Su Oh South Korea Gi‐Su Oh's profile →
Citations per field
00.5×1.5×2.1×
Gi‐Su Oh · 1×
Citations per year

Countries citing papers authored by Takemi Yoshida

Since Specialization
Citations

This map shows the geographic impact of Takemi Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takemi Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takemi Yoshida more than expected).

Fields of papers citing papers by Takemi Yoshida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takemi Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takemi Yoshida. The network helps show where Takemi Yoshida may publish in the future.

Co-authorship network of co-authors of Takemi Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Takemi Yoshida. A scholar is included among the top collaborators of Takemi Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takemi Yoshida. Takemi Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 15
2 30
3 7
4 192
5 27
6 16
7 7
8 33
9 28
10 5
11 45
12 4
13 1
14 24
15 5
16 2
17 18
18 14
19 27
20 3

About Takemi Yoshida

Takemi Yoshida is a scholar working on Pharmacology, Toxicology and Biochemistry, having authored 156 papers that have together received 3.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (41 papers), Heme Oxygenase-1 and Carbon Monoxide (28 papers) and Drug Transport and Resistance Mechanisms (20 papers). The work is most often cited by research in Pharmacology (627 citations), Toxicology (239 citations) and Biological Psychiatry (91 citations). Takemi Yoshida has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Satoshi Numazawa, Yukio Kuroiwa, Yukio Kuroiwa, Kazuyasu Nakaya, Sachiko Tanaka, Seiji Shioda, Takiko Oguro, Shigeo Nakajo, Aya Yoshida and Takashi Ashino. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026